DEVELOPING INNOVATIVE MEDICATIONS FOR PRESERVING SENSORY FUNCTIONS FOR THE HUMAN AND VETERINARY MARKETS
Founded in 2003, Therapeutic Vision is a research pharma company that is developing medications for the preservation of vision, hearing, and neuroprotection for humans and their companion pets. As vison experts, we also offer consultative expertise on identifying toxicological mechanisms on drug-induced cataract development.
Our Products
We are developing topical and oral medications that support sensory health for our human and companion pet populations. For diabetic dogs, we have developed Kinostat®, an eye drop that clinically prevents blinding cataract formation. In preclinical studies our unique oral neuroprotective medications called multifunctional redox modulators (MFRM®s) provide protection against oxidative stress and metal imbalanced associated vision, and hearing loss, as well as the generation of neurotoxic amyloid beta - zinc complex in the brain and eyes. Our OTC nutraceutical ophthalmic formulation in the aging eye delays cataract formation, supports tear flow, reduces tear staining in brachycephalic dogs. These products have passed a series of strict evaluations based on industry requirements so that you can be assured that only high-quality medical treatments are being developed.
Solutions Backed by Science
All products are backed by strong experimental evidence from the studies made by our team. Our researchers are experienced vision scientists, hearing specialists and veterinary ophthalmologists.
